Open access
Open access
Powered by Google Translator Translator

RCT | Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen.

8 Nov, 2022 | 12:06h | UTC

Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: a randomized controlled trial – Journal of Allergy and Clinical Immunology (link to abstract – $ for full-text)

News Release: Monoclonal antibody improves cat allergen immunotherapy – National Institutes of Health 

Commentaries: Study explores the potential use of anti-thymic stromal lymphopoietin monoclonal antibody as an adjuvant in allergic immunotherapy – News Medical

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.